Evidence map›Paper›PMID 28495915›Full record

ArticleHaematologica2017

Extracellular glycine is necessary for optimal hemoglobinization of erythroid cells.

Daniel Garcia-Santos, Matthias Schranzhofer, Richard Bergeron, Alex D Sheftel, Prem Ponka

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Programmed cell death in triple-negative breast cancer.Cellular & molecular biology letters · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. New Avenues of Heme Synthesis Regulation.International journal of molecular sciences · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. NADPH Oxidase Inhibition in Fibrotic Pathologies.Antioxidants & redox signaling · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Daniel Garcia-SantosLady Davis Institute for Medical Research, Jewish General Hospital, and the Department of Physiology, McGill University, Montréal, Quebec, Canada.
Matthias SchranzhoferLady Davis Institute for Medical Research, Jewish General Hospital, and the Department of Physiology, McGill University, Montréal, Quebec, Canada.
Richard BergeronOttawa Hospital Research Institute, University of Ottawa, Ontario, Canada.
Alex D SheftelSpartan Bioscience Inc., Ottawa, Canada.
Prem PonkaLady Davis Institute for Medical Research, Jewish General Hospital, and the Department of Physiology, McGill University, Montréal, Quebec, Canada prem.ponka@mcgill.ca.
Jewish General Hospital · CAMcGill University · CAOttawa Hospital · CASpartan Bioscience (Canada) · CA

Funding

CIHR MOP-126064CIHR MOP-14100
6 · The paper itself

Abstract

Vertebrate heme synthesis requires three substrates: succinyl-CoA, which regenerates in the tricarboxylic acid cycle, iron and glycine. For each heme molecule synthesized, one atom of iron and eight molecules of glycine are needed. Inadequate delivery of iron to immature erythroid cells leads to a decreased production of heme, but virtually nothing is known about the consequence of an insufficient supply of extracellular glycine on the process of hemoglobinization. To address this issue, we exploited mice in which the gene encoding glycine transporter 1 (GlyT1) was disrupted. Primary erythroid cells isolated from fetal livers of GlyT1 knockout (GlyT1

Indexed as

AnimalsErythroid CellsGlycineGlycine Plasma Membrane Transport ProteinsHemeHemoglobinsMiceMice, KnockoutGlycineGlycine Plasma Membrane Transport ProteinsHemeHemoglobinsSlc6a9 protein, mouse

Identifiers

PMID28495915
PMCPMC5541866
OpenAlexW2613829040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.